Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
8.9M
-
Shares change
-
+8.9M
-
Total reported value, excl. options
-
$143M
-
Value change
-
+$143M
-
Number of buys
-
22
-
Price
-
$16.36
Significant Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q1 2021
22 filings reported holding LBPH - LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share as of Q1 2021.
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.9M shares
.
Largest 10 shareholders include Cormorant Asset Management, LP (2.36M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.3M shares), FMR LLC (1.99M shares), Farallon Capital Management, L.L.C. (811K shares), CITIGROUP INC (406K shares), ORBIMED ADVISORS LLC (300K shares), MILLENNIUM MANAGEMENT LLC (190K shares), CITADEL ADVISORS LLC (181K shares), Alyeska Investment Group, L.P. (125K shares), and VANGUARD GROUP INC (55K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.